Conduent Incorporated (CNDT): Price and Financial Metrics


Conduent Incorporated (CNDT): $5.02

-0.10 (-1.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CNDT POWR Grades


  • Growth is the dimension where CNDT ranks best; there it ranks ahead of 97.54% of US stocks.
  • CNDT's strongest trending metric is Growth; it's been moving down over the last 163 days.
  • CNDT's current lowest rank is in the Quality metric (where it is better than 26.9% of US stocks).

CNDT Stock Summary

  • CNDT's current price/earnings ratio is 1,089.51, which is higher than 99.33% of US stocks with positive earnings.
  • With a price/sales ratio of 0.26, CONDUENT Inc has a higher such ratio than only 4.48% of stocks in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CNDT comes in at 24.14% -- higher than that of 91.55% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CONDUENT Inc are CWCO, CIA, FOCS, BRID, and GOOD.
  • Visit CNDT's SEC page to see the company's official filings. To visit the company's web site, go to www.conduent.com.

CNDT Valuation Summary

  • In comparison to the median Technology stock, CNDT's price/earnings ratio is 331.79% lower, now standing at -90.4.
  • Over the past 57 months, CNDT's EV/EBIT ratio has gone up 75.6.
  • Over the past 57 months, CNDT's price/sales ratio has gone down 0.

Below are key valuation metrics over time for CNDT.

Stock Date P/S P/B P/E EV/EBIT
CNDT 2021-09-01 0.4 1.3 -90.4 69.2
CNDT 2021-08-31 0.4 1.3 -91.3 69.6
CNDT 2021-08-30 0.4 1.3 -87.9 68.1
CNDT 2021-08-27 0.4 1.3 -89.1 68.6
CNDT 2021-08-26 0.3 1.2 -84.9 66.9
CNDT 2021-08-25 0.4 1.3 -87.6 68.0

CNDT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CNDT has a Quality Grade of C, ranking ahead of 25.79% of graded US stocks.
  • CNDT's asset turnover comes in at 0.983 -- ranking 133rd of 561 Business Services stocks.
  • FDS, TTD, and ICFI are the stocks whose asset turnover ratios are most correlated with CNDT.

The table below shows CNDT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.983 0.243 0.014
2021-03-31 0.969 0.236 -0.014
2020-12-31 0.961 0.229 -0.027
2020-09-30 0.956 0.226 -0.242
2020-06-30 0.930 0.218 -0.240
2020-03-31 0.902 0.216 -0.604

CNDT Price Target

For more insight on analysts targets of CNDT, see our CNDT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.50 Average Broker Recommendation 1.9 (Hold)

CNDT Stock Price Chart Interactive Chart >

Price chart for CNDT

CNDT Price/Volume Stats

Current price $5.02 52-week high $8.50
Prev. close $5.12 52-week low $4.60
Day low $4.99 Volume 2,005,500
Day high $5.18 Avg. volume 2,427,950
50-day MA $5.45 Dividend yield N/A
200-day MA $6.63 Market Cap 1.07B

Conduent Incorporated (CNDT) Company Bio


Conduent Incorporated provides business process services for healthcare, public sector, and commercial industries in the United States. The Company offers customers in various areas, which include health solutions, learning services, digital payments, legal and compliance solutions, human resources, finance and accounting, procurement solutions and digital transformation. The company is based in Basking Ridge, New Jersey.


CNDT Latest News Stream


Event/Time News Detail
Loading, please wait...

CNDT Latest Social Stream


Loading social stream, please wait...

View Full CNDT Social Stream

Latest CNDT News From Around the Web

Below are the latest news stories about CONDUENT Inc that investors may wish to consider to help them evaluate CNDT as an investment opportunity.

Conduent Receives Comparably Awards as a Best Company for Women and for Diversity

Conduent recognized in two categories among companies with more than 500 employeesFLORHAM PARK, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a business process and solutions company, today announced it has been honored by Comparably with two Best Places to Work Awards for 2021. Conduent was ranked as one of the Best Companies for Women and as one of the Best Companies for Diversity, placing Conduent among the Top 100 highest-rated companies in both categories. “W

Yahoo | January 10, 2022

Conduent To Sell Its Midas Suite of Solutions To symplr For $340M Cash

Conduent Inc (NASDAQ: CNDT) agreed to sell its Midas Suite of Solutions for $340 million in cash to symplr. The sale consists of the Midas suite of patient safety, quality, and advanced analytics solutions, including DataVision and Statit. symplr is a global leader in healthcare operations, including governance, risk management, and compliance SaaS solutions, backed by Clearlake Capital Group, L.P., and Charlesbank Capital Partners. The Midas suite of solutions generated $72 million in 2020 reve

Yahoo | January 4, 2022

Houston health tech firm Symplr adds to acquisition list with $340M deal

The acquisition includes a suite of patient-safety, quality and advanced-analytics services, which are used to support approximately 2,200 health care facilities.

Yahoo | January 4, 2022

Conduent Announces Agreement to Sell its Midas Suite of Solutions to symplr

Transaction expected to close in the first quarter of 2022 Companies to focus on seamless transition for clients and associates FLORHAM PARK, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a business process services and solutions company, today announced a definitive agreement to sell its Midas Suite of Solutions to symplr®, a global leader in healthcare operations, including governance, risk management, and compliance SaaS solutions, backed by Clearlake Capital G

Yahoo | January 4, 2022

SYMPLR TO ACQUIRE MIDAS HEALTH ANALYTICS SOLUTIONS FROM CONDUENT

symplr®, a global leader in enterprise healthcare operations including governance, risk management, and compliance ("GRC") SaaS solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners (together with its affiliates, "Charlesbank"), announced today that it has agreed to acquire Midas Health Analytics Solutions ("Midas") from Conduent Incorporated (Nasdaq: CNDT) ("Conduent"). The transaction is expected to close in the first qu

Yahoo | January 4, 2022

Read More 'CNDT' Stories Here

CNDT Price Returns

1-mo -6.34%
3-mo -26.93%
6-mo -26.28%
1-year -4.38%
3-year -58.99%
5-year -65.52%
YTD -5.99%
2021 11.25%
2020 -22.58%
2019 -41.67%
2018 -34.22%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8261 seconds.